sb 216763 has been researched along with Disease Models, Animal in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (16.67) | 29.6817 |
2010's | 29 (80.56) | 24.3611 |
2020's | 1 (2.78) | 2.80 |
Authors | Studies |
---|---|
Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ | 1 |
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Bai, W; Chen, JF; Chen, X; Chen, XY; Li, P; Liu, D; Ning, YL; Peng, Y; Wang, H; Yang, N; Zhao, Y; Zhao, ZA; Zhou, YG | 1 |
Gao, Y; Hou, J; Shen, L; Wang, L; Zhang, J; Zhu, Y | 1 |
Argenton, F; Basso, C; Beffagna, G; Della Barbera, M; Facchinello, N; Fornetto, C; Giuliodori, A; Marchetto, G; Pilichou, K; Rizzo, S; Santimaria, M; Thiene, G; Tiso, N; Toppo, S; Vanzi, F; Vettori, A | 1 |
He, K; Hua, X; Ma, X; Wu, H; Xia, Q; Zhang, J; Zhou, T; Zhuang, S | 1 |
Dong, L; Hui, J; Jiang, D; Mao, X; Pu, M; Shi, G; Wu, J; Xi, G; Zhang, J; Zhou, X; Zou, J | 1 |
Casal, C; Delgado-Morales, R; Esteller, M; Fourcade, S; Gonzalez-Somermeyer, L; Guil, S; Huertas, D; Jorge-Torres, OC; Llobet, A; Martínez-San Segundo, P; Petazzi, P; Pujol, A; Roa, L; Sáez, MA; Soler, M; Szczesna, K; Velasco, CD | 1 |
Bai, WJ; Hou, K; Hu, WY; Hu, YX; Jiao, Y; Kang, Q; Liu, SY; Liu, ZY; Lv, KY; Ma, N; Qiu, CW; Xiao, ZC; Zhang, FL; Zhang, L | 1 |
Aafaqi, S; Aneq, MÅ; Calkins, H; Chiasson, DA; Codima, A; Davies, RW; El-Refaey, M; Fatah, M; Gardner, MJ; Gollob, MH; Graw, SL; Green, AK; Hamilton, RM; Han, M; Healey, JS; Hegele, RA; Hoorntje, ET; Hund, TJ; James, CA; Janssen, PM; Judge, DP; Kline, CF; Koenig, S; Koopmann, TT; Krahn, AD; Lodder, EM; Lubbers, ER; Marcus, FI; Mestroni, L; Mittal, K; Mohler, PJ; Murphy, NP; Murray, B; Musa, H; Nazer, B; Nguyen, DT; Rafiq, MA; Roberts, JD; Robinson, JF; Scheinman, MM; Simmons, SL; Sinagra, G; Skanes, AC; Sobriera, N; Spears, DA; Sturm, AC; Tang, AS; Taylor, MR; Tichnell, C; Ursell, PC; van den Berg, MP; van Opbergen, CJ; van Tintelen, JP; van Veen, TA; Wilde, AA; Wold, LE | 1 |
Chen, P; Chen, S; Deng, Y; Wei, J; Xiong, Z; Yan, Z | 1 |
Baarsma, HA; Bos, S; Gosens, R; Kerstjens, HA; Langen, RC; Meurs, H; Schols, AM; Smit, M; Visser, KH | 1 |
Baarsma, HA; de Theije, CC; Gosens, R; Haegens, A; Langen, RC; Pansters, NA; Remels, AH; Schols, AM; Verhees, KJ | 1 |
Bai, G; Cao, L; Gao, H; Gui, S; Lu, R; Wang, F; Zhang, Y | 1 |
Ding, X; Fang, Y; Liang, M; Liu, S; Liu, T; Yu, X; Zhang, H | 1 |
Abdillahi, M; Ananthakrishnan, R; Deckelbaum, RJ; Quadri, N; Ramasamy, R; Rosario, R; Wang, L; Zhu, Z; Zirpoli, H | 1 |
Bartesaghi, R; Ciani, E; De Franceschi, M; Fuchs, C; Rimondini, R; Trazzi, S; Viggiano, R | 1 |
D'Angelo, B; Ek, CJ; Mallard, C; Sandberg, M; Sun, Y; Zhu, C | 1 |
Chen, X; Dong, Y; Jiang, B; Lei, S; Li, L; Liu, Y; Tan, L; Wu, J; Yu, S; Zhao, Y; Zhu, J | 1 |
Abbott, GW; Crump, SM; Hu, Z; Zhang, P | 1 |
Meltzer, HY; Ren, ZX; Sun, PH; Wang, JR; Zhen, XC | 1 |
Bauchwitz, RP; Chen, S; Jope, RS; Min, WW; Sikorski, C; Yan, Q; Yuskaitis, CJ | 1 |
Beech, BH; Beech, WK; Begum, AN; Chen, P; Cole, GM; Davies, P; Frautschy, SA; Hu, S; Jones, MR; Kim, PC; Ma, Q; Oh, MS; Ubeda, OJ; Yang, F | 1 |
Alexander, J; Aronin, N; Chase, K; DiFiglia, M; Kegel, KB; Li, X; Reeves, PB; Sapp, E; Valencia, A | 1 |
Bae, GS; Chong, MS; Hwang, SY; Jung, WS; Kim, DY; Kim, EK; Kim, HJ; Kim, MS; Kwon, KB; Park, CS; Park, HJ; Park, RK; Park, SJ; Seo, SW; Song, HJ; Song, MY | 1 |
Clanachan, AS; Omar, MA; Wang, L | 1 |
Dawson, LA; Kalinichev, M | 1 |
Bertolotti, P; Carruba, MO; De Simoni, MG; Delbarba, A; Dossena, M; Nisoli, E; Perego, C; Ragni, M; Spano, P; Valerio, A | 1 |
Akhmetshina, A; Bergmann, C; Beyer, C; Dees, C; Distler, JH; Distler, O; Palumbo, K; Schett, G; Zerr, P; Zwerina, J | 1 |
Allan, AM; Guo, W; Johnson, EB; Murthy, AC; Schaller, EG; Zhang, L; Zhao, X | 1 |
Lu, L; Pu, LY; Sun, BC; Wang, XH; Wu, ZS; Xia, YX | 1 |
Chen, L; Chen, Y; Duan, Z; Han, Y; Ma, Y; Piao, Z; Ren, F; Wen, T; Zhang, H; Zhang, J; Zheng, S; Zhou, L | 1 |
Dang, YH; Gao, CG; Hashimoto, K; Jia, M; Ma, R; Ma, XC; Wang, F; Wu, J | 1 |
Gross, ER; Gross, GJ; Hsu, AK | 1 |
Mozaffari, MS; Schaffer, SW | 1 |
Derumeaux, G; Gomez, L; Ovize, M; Paillard, M; Thibault, H | 1 |
36 other study(ies) available for sb 216763 and Disease Models, Animal
Article | Year |
---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Adenosine A
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adult; Aged; Animals; Brain Injuries, Traumatic; Cognitive Dysfunction; Disease Models, Animal; Female; Glycogen Synthase Kinase 3 beta; Glycogen Synthase Kinases; Hippocampus; Humans; Indoles; Isoquinolines; Male; Maleimides; Mice; Mice, Knockout; Middle Aged; Neurons; Phenethylamines; Phosphorylation; Protein Kinase Inhibitors; Receptor, Adenosine A2A; Signal Transduction; Sulfonamides; tau Proteins; Triazines; Triazoles | 2017 |
Effects of chronic alcohol exposure on ischemia-reperfusion-induced acute kidney injury in mice: the role of β-arrestin 2 and glycogen synthase kinase 3.
Topics: Acute Kidney Injury; Alcoholism; Analysis of Variance; Animals; beta-Arrestin 2; Blood Alcohol Content; Blood Urea Nitrogen; Creatinine; Disease Models, Animal; Fibrosis; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Kidney; Male; Maleimides; Mice; Mice, Inbred C57BL; Mice, Knockout; Myofibroblasts; Reperfusion Injury | 2017 |
Loss of cardiac Wnt/β-catenin signalling in desmoplakin-deficient AC8 zebrafish models is rescuable by genetic and pharmacological intervention.
Topics: Animals; Animals, Genetically Modified; Arrhythmogenic Right Ventricular Dysplasia; Desmoplakins; Disease Models, Animal; Gene Expression Regulation, Developmental; Gene Knockdown Techniques; Indoles; Maleimides; Morphogenesis; Myocardium; Oligonucleotides, Antisense; Wnt Signaling Pathway; Zebrafish; Zebrafish Proteins | 2018 |
Inhibition of GSK-3β induces AP-1-mediated osteopontin expression to promote cholestatic liver fibrosis.
Topics: Adolescent; Animals; Child; Disease Models, Animal; Female; Gene Expression Regulation; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Liver; Liver Cirrhosis; Male; Maleimides; Mice; Mice, Inbred C57BL; Osteopontin; Signal Transduction; Transcription Factor AP-1; Up-Regulation | 2018 |
Modulation of GSK-3β/β-Catenin Signaling Contributes to Learning and Memory Impairment in a Rat Model of Depression.
Topics: Animals; beta Catenin; Cognitive Dysfunction; Corticosterone; Depressive Disorder; Disease Models, Animal; Gene Transfer Techniques; Glycogen Synthase Kinase 3 beta; Hippocampus; Indoles; Intercellular Signaling Peptides and Proteins; Learning Disabilities; Male; Maleimides; Maze Learning; Memory Disorders; Nootropic Agents; Rats, Sprague-Dawley; Signal Transduction; Stress, Psychological; Uncertainty | 2018 |
Inhibition of Gsk3b Reduces Nfkb1 Signaling and Rescues Synaptic Activity to Improve the Rett Syndrome Phenotype in Mecp2-Knockout Mice.
Topics: Animals; Biomarkers; Cells, Cultured; Cerebellum; Dendritic Spines; Disease Models, Animal; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Inflammation; Longevity; Maleimides; Methyl-CpG-Binding Protein 2; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B p50 Subunit; Phenotype; Protein Kinase Inhibitors; Rett Syndrome; Signal Transduction; Survival Analysis; Synapses; Up-Regulation | 2018 |
Wip1 knockout inhibits neurogenesis by affecting the Wnt/β-catenin signaling pathway in focal cerebral ischemia in mice.
Topics: Animals; beta Catenin; Brain Infarction; Bromodeoxyuridine; Disease Models, Animal; Doublecortin Domain Proteins; Enzyme Inhibitors; Gene Expression Regulation; In Situ Nick-End Labeling; Indoles; Infarction, Middle Cerebral Artery; Male; Maleimides; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microtubule-Associated Proteins; Neurogenesis; Neuropeptides; Protein Phosphatase 2C; Severity of Illness Index; Statistics, Nonparametric; Wnt Signaling Pathway | 2018 |
Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapy.
Topics: Animals; Ankyrins; Arrhythmogenic Right Ventricular Dysplasia; beta Catenin; Disease Models, Animal; Female; Humans; Indoles; Male; Maleimides; Mice; Mice, Knockout; Myocardium; Wnt Signaling Pathway | 2019 |
β-amyloid impairs the regulation of N-methyl-D-aspartate receptors by glycogen synthase kinase 3.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Glycogen Synthase Kinase 3; Indoles; Male; Maleimides; Mice; Mice, Transgenic; Molecular Targeted Therapy; N-Methylaspartate; Neuronal Plasticity; Neurons; rab5 GTP-Binding Proteins; Rats; Receptors, N-Methyl-D-Aspartate | 2014 |
Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: I. Effects on lung remodeling and pathology.
Topics: Animals; beta Catenin; Collagen; Disease Models, Animal; Enzyme Inhibitors; Fibronectins; Glycogen Synthase Kinase 3; Guinea Pigs; Indoles; Lipopolysaccharides; Lung; Male; Maleimides; Muscle, Smooth; Pulmonary Disease, Chronic Obstructive; Signal Transduction; Smad Proteins | 2013 |
Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: II. Effects on skeletal muscle atrophy.
Topics: Animals; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Glucocorticoids; Glycogen Synthase Kinase 3; Guinea Pigs; Indoles; Lipopolysaccharides; Male; Maleimides; Muscle Development; Muscle, Skeletal; Muscular Atrophy; Pulmonary Disease, Chronic Obstructive; Tumor Necrosis Factor-alpha | 2013 |
Effects of the estrogen receptor antagonist fulvestrant on F344 rat prolactinoma models.
Topics: Animals; Cell Line, Transformed; Disease Models, Animal; DNA Methylation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Extracellular Matrix Proteins; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Indoles; Intercellular Signaling Peptides and Proteins; Maleimides; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats; Rats, Inbred F344; Time Factors | 2014 |
Limb ischemic preconditioning protects against contrast-induced acute kidney injury in rats via phosphorylation of GSK-3β.
Topics: Acute Kidney Injury; Androstadienes; Animals; Apoptosis; Chromones; Contrast Media; Disease Models, Animal; Gene Expression Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Indoles; Iohexol; Ischemic Preconditioning; Kidney Tubules; Male; Maleimides; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Morpholines; Nephrectomy; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Wortmannin | 2015 |
Acute administration of n-3 rich triglyceride emulsions provides cardioprotection in murine models after ischemia-reperfusion.
Topics: Animals; Apoptosis Regulatory Proteins; Beclin-1; Chromones; Disease Models, Animal; Echocardiography; Emulsions; Fatty Acids, Omega-3; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Indoles; Male; Maleimides; Mice; Mice, Inbred C57BL; Morpholines; Myocardial Reperfusion Injury; Phosphorylation; PPAR gamma; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Signal Transduction | 2015 |
Inhibition of GSK3β rescues hippocampal development and learning in a mouse model of CDKL5 disorder.
Topics: Animals; Apoptosis; Cell Survival; Disease Models, Animal; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Indoles; Learning Disabilities; Male; Maleimides; Maze Learning; Mice, Knockout; Neural Stem Cells; Neurogenesis; Neurons; Neuroprotective Agents; Nootropic Agents; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Spatial Memory | 2015 |
GSK3β inhibition protects the immature brain from hypoxic-ischaemic insult via reduced STAT3 signalling.
Topics: Animals; Animals, Newborn; Brain; Brain Infarction; Caspase 3; Cerebrovascular Circulation; Disease Models, Animal; Doublecortin Domain Proteins; Drug Administration Schedule; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Hypoxia-Ischemia, Brain; Indoles; Maleimides; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Nerve Tissue Proteins; Neuropeptides; STAT3 Transcription Factor; Stem Cells; Subcellular Fractions | 2016 |
GSK-3β downregulates Nrf2 in cultured cortical neurons and in a rat model of cerebral ischemia-reperfusion.
Topics: Animals; Brain Ischemia; Cells, Cultured; Disease Models, Animal; Down-Regulation; Gene Expression Regulation; Gene Silencing; Glycogen Synthase Kinase 3 beta; Indoles; Lithium Chloride; Male; Maleimides; Neurons; NF-E2-Related Factor 2; Rats; Signal Transduction | 2016 |
Kcne2 deletion attenuates acute post-ischaemia/reperfusion myocardial infarction.
Topics: Animals; Disease Models, Animal; Indoles; Ischemia; Maleimides; Mice, Knockout; Myocardial Infarction; Myocardial Reperfusion Injury; Phosphorylation; Potassium Channels, Voltage-Gated | 2016 |
GSK-3β Interacts with Dopamine D1 Receptor to Regulate Receptor Function: Implication for Prefrontal Cortical D1 Receptor Dysfunction in Schizophrenia.
Topics: Adjuvants, Immunologic; Animals; beta-Arrestins; Cyclic AMP; Disease Models, Animal; Dopamine Agonists; Endocytosis; Enzyme Inhibitors; Fenoldopam; Glycogen Synthase Kinase 3 beta; Guanosine 5'-O-(3-Thiotriphosphate); HEK293 Cells; Humans; Indoles; Lithium Chloride; Maleimides; Prefrontal Cortex; Protein Transport; Rats; Receptors, Dopamine D1; Schizophrenia | 2017 |
Elevated glycogen synthase kinase-3 activity in Fragile X mice: key metabolic regulator with evidence for treatment potential.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Antimanic Agents; Brain; Citrates; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Exploratory Behavior; Fragile X Mental Retardation Protein; Gene Expression Regulation; Glycogen Synthase Kinase 3; Indoles; Lithium Chloride; Male; Maleimides; Mice; Mice, Knockout; Pyridines; Seizures; Serine; Thiazoles; Urea | 2009 |
GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Caspase 3; Cells, Cultured; Disease Models, Animal; DNA Fragmentation; Enzyme Inhibitors; Gliosis; Glycogen; Glycogen Synthase Kinase 3; Hippocampus; Indoles; JNK Mitogen-Activated Protein Kinases; Maleimides; Maze Learning; Nerve Degeneration; Neurons; Phosphorylation; Rats; Rats, Sprague-Dawley; tau Proteins | 2009 |
Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
Topics: Analysis of Variance; Animals; Blotting, Western; Cell Fractionation; Cell Survival; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Glycogen Synthase Kinase 3; Huntingtin Protein; Huntington Disease; Indoles; Maleimides; Membrane Microdomains; Mice; Mice, Transgenic; Microscopy, Confocal; Nerve Degeneration; Nerve Tissue Proteins; Neurons; Nuclear Proteins | 2010 |
Selective GSK-3beta inhibitors attenuate the cisplatin-induced cytotoxicity of auditory cells.
Topics: Acoustic Stimulation; Animals; Antineoplastic Agents; Apoptosis; Caspases; Cell Line; Cisplatin; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Evoked Potentials, Auditory, Brain Stem; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hair Cells, Auditory; Hearing Loss; Indoles; Injections, Intraperitoneal; Interleukin-1beta; Interleukin-6; Lithium Chloride; Maleimides; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Organ Culture Techniques; Organ of Corti; Phosphorylation; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Time Factors; Tumor Necrosis Factor-alpha | 2009 |
Cardioprotection by GSK-3 inhibition: role of enhanced glycogen synthesis and attenuation of calcium overload.
Topics: Animals; Calcium; Cardiotonic Agents; Disease Models, Animal; Down-Regulation; Glucose; Glycogen; Glycogen Synthase Kinase 3; Glycolysis; Hydrogen-Ion Concentration; In Vitro Techniques; Indoles; Male; Maleimides; Myocardial Reperfusion Injury; Myocardium; Palmitic Acid; Perfusion; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Recovery of Function; Sodium-Calcium Exchanger; Sodium-Hydrogen Exchangers; Time Factors; Up-Regulation; Ventricular Function, Left | 2010 |
Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania.
Topics: Amphetamine; Animals; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Blood-Brain Barrier; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glycogen Synthase Kinase 3; Humans; Indoles; Male; Maleimides; Mice; Mice, Mutant Strains; Molecular Targeted Therapy; Motor Activity; Reproducibility of Results; Thiadiazoles; Thiazoles; Urea | 2011 |
Glycogen synthase kinase-3 inhibition reduces ischemic cerebral damage, restores impaired mitochondrial biogenesis and prevents ROS production.
Topics: Animals; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; DNA-Binding Proteins; DNA, Mitochondrial; Dose-Response Relationship, Drug; Embryo, Mammalian; Enzyme Inhibitors; Glucose; Glycogen Synthase Kinase 3; High Mobility Group Proteins; Hypoxia; Indoles; Infarction, Middle Cerebral Artery; L-Lactate Dehydrogenase; Maleimides; Mice; Mitochondria; Mutation; Neurons; Nuclear Respiratory Factor 1; Organelle Biogenesis; Reactive Oxygen Species; RNA, Messenger; Transfection | 2011 |
Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway.
Topics: Animals; Bleomycin; Cells, Cultured; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Fibroblasts; Fibrosis; Gene Knockdown Techniques; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Male; Maleimides; Mice; Mice, Inbred DBA; RNA, Small Interfering; Scleroderma, Systemic; Skin; Wnt Signaling Pathway | 2011 |
Inhibition of GSK3β improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome.
Topics: Animals; Disease Models, Animal; Fragile X Mental Retardation Protein; Fragile X Syndrome; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Indoles; Learning; Male; Maleimides; Mice; Mice, Knockout; Nerve Net; Neurogenesis; Neurons; Phosphorylation; Protein Kinase Inhibitors | 2012 |
Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
Topics: Alanine Transaminase; Animals; Apoptosis; Axin Protein; beta Catenin; Blotting, Western; Cell Proliferation; Cyclin D1; Disease Models, Animal; Gene Expression Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Immunohistochemistry; Indoles; Inhibitor of Apoptosis Proteins; Liver; Liver Regeneration; Male; Maleimides; Mice; Mice, Inbred C57BL; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Real-Time Polymerase Chain Reaction; Reperfusion Injury; Repressor Proteins; Signal Transduction; Survivin; Time Factors | 2012 |
Inhibition of glycogen synthase kinase 3β ameliorates D-GalN/LPS-induced liver injury by reducing endoplasmic reticulum stress-triggered apoptosis.
Topics: Animals; Apoptosis; Caspase 12; Disease Models, Animal; Endoplasmic Reticulum Stress; Enzyme Activation; Enzyme Inhibitors; Galactosamine; Gene Expression Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Indoles; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Maleimides; Mice; Mitogen-Activated Protein Kinase Kinases; Signal Transduction; Toll-Like Receptor 4; Transaminases; Transcription Factor CHOP | 2012 |
Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Depressive Disorder; Disease Models, Animal; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Hindlimb Suspension; Humans; Indoles; Ketamine; Male; Maleimides; Mice; Motor Activity; Stress, Physiological; Sucrose | 2013 |
GSK3beta inhibition and K(ATP) channel opening mediate acute opioid-induced cardioprotection at reperfusion.
Topics: Analgesics, Opioid; Androstadienes; Animals; Benzamides; Benzopyrans; Blood Pressure; Cardiotonic Agents; Disease Models, Animal; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Guanidines; Heart Rate; Imidazoles; Indoles; Ion Channel Gating; Male; Maleimides; Morphine; Myocardial Infarction; Myocardial Reperfusion Injury; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Potassium Channel Blockers; Potassium Channels; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Sarcolemma; Signal Transduction; Time Factors; Wortmannin | 2007 |
Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore.
Topics: Animals; Cardiotonic Agents; Cyclosporine; Diazoxide; Disease Models, Animal; Glyburide; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hypertension; In Vitro Techniques; Indoles; Lithium Chloride; Male; Maleimides; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Perfusion; Potassium Channel Blockers; Potassium Channels; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Ventricular Function, Left; Ventricular Pressure | 2008 |
Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion.
Topics: Animals; Cyclosporine; Disease Models, Animal; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Indoles; Ischemic Preconditioning, Myocardial; Maleimides; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Electron; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxidative Phosphorylation; Phosphorylation | 2008 |